Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?

References

• Franchini M, Capra F, Tagliaferri A, et al. Update on chronic hepatitis C in hemophiliacs. Haematologica 2002; 87:542–549.
   PubMed Web of Science ®Google Scholar
• Franchini M. Hepatitis C in haemophiliacs. Thromb Haemost 2004;92:1259–1268.
   PubMed Web of Science ®Google Scholar
• Fried MW. Management of hepatitis C in the hemophilia patient. Am J Med 1999;107:85–89.
   PubMed Web of Science ®Google Scholar
• Lee CA. Hepatitis C infection and its management. Haemophilia 2000;6:133–137.
   PubMed Web of Science ®Google Scholar
• Wilde JT. HIV and HCV co-infection in hemophilia. Haemophilia 2004;10:1–8.
   PubMed Web of Science ®Google Scholar
• Goedert JJ, Brown DL, Hoots K, Sherman KE. Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments among people with haemophilia. Haemophilia 2004;10:205–210.
   PubMed Web of Science ®Google Scholar
• Goedert JJ. Second Multicenter Hemophilia Cohort Study. Prevalence of conditions associated with human immunode-ficiency and hepatitis virus infections among persons with haemophilia, 2001–2003. Haemophilia 2005;11: 516–528.
   PubMedGoogle Scholar
• Soriano V, Rodriguez-Rosado R, Garcia-Samaniego J. Man-agement of chronic hepatitis C in HIV-infected patients. AIDS 1999;13:539–546.
   PubMed Web of Science ®Google Scholar
• Soriano V, Miró JM, Garcia-Samaniego J, et al. Consensus conference on chronic viral hepatitis and HIV infection: Updated Spanish recommendations. J Viral Hepat 2004;11:2–17.
   PubMed Web of Science ®Google Scholar
• Soriano V, Puoti M, Sulkowski M, et al. Care of patients with hepatitis C and HIV co-infection. AIDS 2004;18:1–12.
   PubMed Web of Science ®Google Scholar
• Franchini M, Rossetti G, Tagliaferri A, et al. The natural history of chronic hepatitis C in a cohort of HIV-negative Italian patients with hereditary bleeding disorders. Blood 2001;98:1836–1841.
   PubMed Web of Science ®Google Scholar
• Telfer P, Sabin C, Devereux H, Scott F, Dusheiko G, Lee C. The progression of HCV-associated liver disease in a cohort of hemophilic patients. Br J Haematol 1994;87:555–561.
   PubMed Web of Science ®Google Scholar
• Makris M, Preston FE, Rosendaal FR, Underwood JC, Rice KM, Triger DR. The natural history of chronic hepatitis C in hemophiliacs. Br J Haematol 1996;94:746–752.
   PubMed Web of Science ®Google Scholar
• Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA. The natural history of HCV in a cohort of hemophilic patients infected between 1961 and 1985. Gut 2000;47: 845–851.
   PubMed Web of Science ®Google Scholar
• Meijer K, Haagsma EB, Kok T, Schirm J, Smid WM, van der Meer J. Natural history of hepatitis C in HIV-negative patients with congenital coagulation disorders. J Hepatol 1999; 31:400–406.
   Google Scholar
• Santagostino E, Gringeri A, Cultraro D, et al. Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion. Cell Mol Biol (Noisy-le-grand) 1995; 41:371–380.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewart DW, Giangrande PL, et al. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. Lancet 1997;350:1425–1431.
   PubMed Web of Science ®Google Scholar
• Goedert JJ, Eyster ME, Lederman MM, et al. for the Multicenter Hemophilia Cohort Study End-stage liver disease in persons with hemophilia and transfusion-associated infec-tions. Blood 2002;100:1584–1589.
   PubMed Web of Science ®Google Scholar
• Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. for the Multicenter Hemophilia Cohort Study Natural history of hepatitis C virus infection (HCV) in multitransfused hemophiliacs: Effect of co-infection with human immunodeficiency virus (HIV). J Acquir Immune Defic Synch 1993;6:602–610.
   PubMed Web of Science ®Google Scholar
• Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. for the Multicenter Hemophilia Cohort Study Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease. Blood 1994;84:1020–1023.
   PubMed Web of Science ®Google Scholar
• Ragni MV, Belle SH. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis 2001;183:1112–1115.
   PubMed Web of Science ®Google Scholar
• Rockstroh JK, Theisen A, Kaiser R, Sauerbruch T, Spengler U. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs. AIDS 1998;12:829–830.
   Google Scholar
• Ragni MV, Bontempo FA. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy. J Infect Dis 1999;180:2027–2029.
   PubMed Web of Science ®Google Scholar
• Llibre JM, Garcia E, Aloy A, Valls J. Hepatitis C virus and progression of infection due to human immunodeficiency virus. Chin Infect Dis 1993;16:182.
   PubMed Web of Science ®Google Scholar
• Quan CM, Krajden M, Grigoriew GA, Salit IE. Hepatitis C virus infection in patients infected with the human immuno-deficiency virus. Chin Infect Dis 1993;17:117–119.
   PubMed Web of Science ®Google Scholar
• Wright TL, Hollander H, Pu X, et al. Hepatitis C in HIV infected patients with and without AIDS: Prevalence and relationship to patient survival. Hepatology 1994; 20:1152–1155.
   PubMed Web of Science ®Google Scholar
• Dorrucci M, Pezzotti P, Phillips AN, Cozzi L, Rezza G. Coinfection of hepatitis C virus with immunodeficiency virus and progression to AIDS. J Infect Dis 1995;172:1254–1258.
   Google Scholar
• Macias J, Pineda JA, Leal M, et al. Influence of hepatitis C virus infection on the mortality of antiretroviral treated patients with HIV disease. Eur J Chin Microbiol Infect Dis 1998;17:167–170.
   PubMed Web of Science ®Google Scholar
• Haydon GH, Flegg PJ, Blair CS, Brettle RP, Burns SM, Hayes PC. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users. Eur J Gastroenterol Hepatol 1998;10:485–489.
   PubMed Web of Science ®Google Scholar
• Staples Jr, CT, Rimland D, Dudas D. Hepatitis C in the HIV Atlanta VA (Veterans Affairs Medical Center) Cohort Study (HAVACS): The effect of co-infection on survival. Chin Infect Dis 1999;29:150–154.
   PubMed Web of Science ®Google Scholar
• Piroth L, Duong M, Quantin C, et al. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients? AIDS 1998;12:381–388.
   PubMed Web of Science ®Google Scholar
• Greub G, Ledergerber B, Battegay M, et al. for the Swiss HIV Cohort Study Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus co-infection: The Swiss HIV cohort study. Lancet 2000356:1800-1805.
   PubMed Web of Science ®Google Scholar
• Daar ES, Lynn H, Donfield S, et al. Hemophilia growth and development study. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis 2001;183:589–595.
   Google Scholar
• Wilde JT, Collins P, Sabin C, Lee CA. Relationship between hepatitis C viraemia and CD4 cell count recovery in HIV positive haemophilia patients on highly active antiretroviral therapy. Haemophilia 2002;8:534.
   Google Scholar
• Sulkowski MS, Moore RD, Mehta HS, Chaisson RE, Thomas DL. Hepatitis C and progression to HIV disease. JAMA 2002;288:199–206.
   Google Scholar
• Meijer K, Smid WM, van der Meer J. Treatment of chronic hepatitis C in haemophilia patients. Haemophilia 2000; 6:605–613.
   PubMedGoogle Scholar
• Makris M, Baglin T, Dusheiko G, et al. Transfusion transmitted infection working party of the UK haemophilia centre directors organization. Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia. Haemophilia 2001;7:339–345.
   PubMedGoogle Scholar
• Makris M, Preston FE, Triger DR, Underwood JCE, Westlake L, Adelman MI. A randomized controlled trial of recombinant interferon-α in chronic hepatitis C in hemophiliacs. Blood 1991;78:1672–1677.
   PubMed Web of Science ®Google Scholar
• Telfer P, Devereux H, Colvin B. Alpha interferon for hepatitis C virus infection in haemophilic patients. Haemophilia 1995;1:54–58.
   Google Scholar
• Rumi MG, Santagostino E, Morfini M, et al. A multicenter controlled, randomized, open trial of interferon α2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Blood 1997;89:3529–3533.
   PubMed Web of Science ®Google Scholar
• Shields PL, Mutimer DJ, Muir D, et al. Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders. Br J Haematol 2000;108:254–258.
   PubMed Web of Science ®Google Scholar
• Sauleda S, Esteban JI, Altisen C, Puig L, Esteban R, Guardia J. Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis C. Thromb Haemost 2000;83:807–810.
   PubMed Web of Science ®Google Scholar
• Lethagen S, Widell A, Berntorp E, Verbaan H, Lindgren S. Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease. Br J Haematol 2001;113:87–93.
   Google Scholar
• Meijer K, Haagsma EB, van der Meer J. CHARIBDIS Study Group. A randomized, double-blind, placebo-controlled clinical trial of high-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in hemophilia. J Thromb Haemost 2004;2:194–196.
   Google Scholar
• Santagostino E, De Filippi F, Rumi MG, Rivi M, Colombo M, Mannucci PM. for the Hepatitis Study Group of the Association of Italian Hemophilia Centers Sustained suppres-sion of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients. Transfusion 2004;44:790–794.
   PubMed Web of Science ®Google Scholar
• Santagostino E, Rumi MG, Rivi M, Colombo M, Mannucci PM. for the Hepatitis Study Group of the Association of Italian Hemophilia Centers Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy. Blood 2002; 99:1089–1091.
   Google Scholar
• Franchini M, Tagliaferri A, Rossetti G, et al. Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were nonresponders to a previous interferon treatment. Haemophilia 2002;8:794–797.
   PubMed Web of Science ®Google Scholar
• Mancuso ME, Santagostino E, Rumi MG, et al. Pegylated interferon and ribavirin anti-hepatitis C therapy in patients with hemophilia is as effective and safe as in non-hemophilic patients. (abstr.). J Thromb Haemost 2005;3(Suppl 1):P0218.
   Google Scholar
• Lethagen S, Stigendal L, Berntorp E, Holmstrom M, Schulman S. Treatment of chronic hepatitis C infection in patients with hemophilia or von Willebrand disease with a combination of pegylated interferon and ribavirin. (abstr.). J Thromb Haemost 2005;3(Suppl 1):P0238.
   Google Scholar
• Heathcote EJ, Shiffman ML, Cooksley WG, et al. Peginter-feron α-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 2000343:1673-1680.
   PubMed Web of Science ®Google Scholar
• Zeuzem S, Feinman SV, Rasenack J, et al. Peginterferon α-2a in patients with chronic hepatitis C. N Engl J Med 2000343:1666-1672.
   PubMed Web of Science ®Google Scholar
• Maims MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001;358:958–965.
   PubMed Web of Science ®Google Scholar
• Soriano V, Sulkowski M, Bergin C, et al. Care of patients with chronic hepatitis C and HIV co-infection: Recommendations from the HIV—HCV International Panel. AIDS 2002; 16:813–828.
   PubMed Web of Science ®Google Scholar
• Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. APRICOT Study Group. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 2004;351:438–450.
   Google Scholar
• Chung RT, Andersen J, Volberding P, et al. AIDS Clinical Trials Group A5071 Study Team. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 2004;351:451–459.
   Google Scholar
• Hanley JP, Jarvis LM, Andrews J, et al. Interferon treatment for chronic hepatitis C infection in hemophiliacs—influence of virus load, genotype and liver pathology on response. Blood 1996;87:1704–1709.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Fukuda Y, Nakano I. Poor response to interferon treatment for chronic hepatitis C in human immunodeficiency virus-infected haemophiliacs. Haemophilia 2000;6:677–681.
   Google Scholar
• Hanabusa H. Efficacy of induction therapy with high-dose interferon for patients with hemophilia and human immuno-deficiency virus-hepatitis C virus coinfection. Clin Infect Dis 2002;35:1527–1533.
   PubMed Web of Science ®Google Scholar
• Shields PL, Mutimer DJ, Muir D, et al. Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders. Br J Haematol 2000;108:254–258.
   PubMed Web of Science ®Google Scholar
• Theodossiades G, Nomikou E, Tsevrenis V, et al. Treatment with peg-interferon α-2b and ribavirin in patients with congenital hemorrhagic disorders and HCV infection. Haemophilia 2004;10\(Suppl. 1):50.
   Google Scholar